Factors Related to Truth Telling in Primary Caregivers

August 21, 2014 updated by: National Taiwan University Hospital

Explore Factors Related to Truth Telling in Primary Caregivers of Children Newly Diagnosed With Cancer

The purpose in this study was to investigate the current status, changes, correlation, and predictive factors of the truth telling, hope, care burden, and quality of life during treatment in primary caregivers of newly diagnosed children with cancer.

Study Overview

Detailed Description

Background: Over the last 50 years, telling truth in adult with cancer was direct. However, studies of truth telling in newly diagnosed children with cancer were seldom. Explore the factors and experiences related to truth telling in primary caregivers of children newly diagnosis with cancer were seldom too. Therefore, we could not estimate the current status of truth telling in primary caregivers of newly diagnosed children with cancer.

Purpose: The purpose in this study was to investigate the current status, changes, correlation, and predictive factors of the truth telling, hope, care burden, and quality of life during treatment in primary caregivers of newly diagnosed children with cancer.

Method: Purposive sampling structured questionnaire, used longitudinal resistance, repeated measurements, correlational design. SAS 9.3 for Windows was used for data entry and analyze. By using the frequency, percentage, mean, and standard deviation to describe demographic information and current status of truth telling. By using the mean, standard deviation, maximum and minimum to analyze hope, care burden, and quality of life. Demographic information, medical information data, truth telling, Herth Hope Index, caregiver burden scale, and quality of life index were tested by Pearson correlation coefficients; the change and predictors about truth telling, Herth Hope Index, caregiver burden scale, and quality of life index were tested by Generalized estimating equation.

Limitation: Studying in one medical center in Taipei, it could not estimate the country's primary caregivers of newly diagnosed children with cancer in conclusions. Because of the limitation of the manpower, time and case numbers, study tracked only six month, could not be assessed the long-term change of the Herth Hope Index, caregiver burden scale, truth telling and quality of life in primary caregivers of newly diagnosed children with cancer.

Study Type

Observational

Enrollment (Anticipated)

84

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Taipei, Taiwan
        • Recruiting
        • National Taiwan University Hospital
        • Contact:
          • SHIANN-TARNG JOU, PhD
          • Phone Number: 71716 +886-2-23123456
          • Email: stjou4@gmail.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Primary Caregivers of Children Newly Diagnosed with Cancer

Description

Inclusion Criteria:

  • Primary caregivers of children newly diagnosed with cancer must be aged 20 years or older.
  • Who can communicate in Chinese and Taiwanese.
  • Consciousness clear.
  • Normal cognitive function.
  • After the explanation, agreed to participate in the study and signed a consent form.
  • The age of children newly diagnosed with cancer is between 0 and 18 years old, who are newly diagnosed with cancer, before determined treatment plan.
  • The physician of children newly diagnosed with cancer, who were willing to participate this study and signed a consent form.

Exclusion Criteria:

  • Primary caregivers of children newly diagnosed with cancer, who have been diagnosed mental illness.
  • The children were cancer recurrence.
  • The physician of children newly diagnosed with cancer, who were not willing to participate this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
primary caregivers of children newly diagnosed with cancer
Explore Factors related to Truth Telling in Primary Caregivers of Children Newly Diagnosed with Cancer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
primary caregivers' Herth Hope Index
Time Frame: Change from baseline at family meeting at 3 months, and at 6 months

The scores of primary caregivers' Herth Hope Index change from baseline at family meeting at 3 months, and at 6 months.

We use Herth Hope Index(HHI) to evaluate the hope that the primary caregivers' care their child during treatment.

There are twelve questions in the Herth Hope Index. The total score is from 12 to 48. Cronbach's α is .89. Retest is .80. Two weeks retest is .86.

The higher the score is, the greater the hope is.

Change from baseline at family meeting at 3 months, and at 6 months
primary caregivers' quality of life index
Time Frame: Change from baseline at family meeting at 3 months, and at 6 months

The scores of primary caregivers' quality of life index change from baseline at family meeting at 3 months, and at 6 months.

We use quality of life index(Q.L.I) to evaluate the quality of life that the primary caregivers' care their child during treatment.

There are 66 questions in the quality of life index. The total score is from 66 to 264. Cronbach's α is .95. Two weeks retest is .87.

Change from baseline at family meeting at 3 months, and at 6 months
primary caregivers' truth telling
Time Frame: Change from baseline at family meeting at 3 months, and at 6 months

The primary caregivers' truth telling change from baseline at family meeting at 3 months, and at 6 months.

Asking the primary caregivers' about that if you tell your child that he/she got the cancer, if you tell your child that he/she the treatment in future, and if you tell your child that he/she the rate of survival.

Change from baseline at family meeting at 3 months, and at 6 months
primary caregivers' care burden
Time Frame: Change from baseline at family meeting at 3 months, and at 6 months

The scores of primary caregivers' care burden change from baseline at family meeting at 3 months, and at 6 months.

We use Questionnaire of care burden to evaluate the care burde that the primary caregivers' care their child during treatment.

There are 20 questions in the quality of life index. The total score is from 0 to 60. Cronbach's α is .91.

The higher the score is, the heavier the care burden is.

Change from baseline at family meeting at 3 months, and at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: SHIANN-TARNG JOU, PhD, National Taiwan University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2014

Primary Completion (ANTICIPATED)

December 1, 2014

Study Completion (ANTICIPATED)

December 1, 2014

Study Registration Dates

First Submitted

December 10, 2013

First Submitted That Met QC Criteria

August 10, 2014

First Posted (ESTIMATE)

August 12, 2014

Study Record Updates

Last Update Posted (ESTIMATE)

August 22, 2014

Last Update Submitted That Met QC Criteria

August 21, 2014

Last Verified

August 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • 201311041RINC

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Primary Caregivers of Children Newly Diagnosed With Cancer

Subscribe